• Who We Are
  • How We Partner
  • Solutions
  • Therapeutic Depth
  • News
    • Happy New Year – 2025!
    • Tips to Quell “Firefighting” in Clinical Research
    • Now Playing on ACRPtv!
    • “7 Breakthrough Behaviors” at PMI NJ Meeting
    • Clinical Trial Financial Management – Live Virtual Training
    • Join us for an interactive webinar!
    • Exciting News! 3Sixty Pharma Solutions Partners with Westchester Biotech Project
    • Join me for an interactive webinar!
    • 3Sixty Pharma Solutions’ CEO to Speak at the Functional Services CRO Partnerships Conference
    • Successful Submission of Start-Up Biotech Investigational New Drug Application
    • See You at the Rare Disease Research Symposium 2019
    • Want to apply for NIH funding, but not sure where to start?
    • ‘Thank You’ for Attending ACRP Presentations!
    • Great Conversations at ACRP in Nashville!
  • Contact Us
  • Privacy Policy

  • Admin

    June 10, 2016

    GI-targeted oral JAK inhibitor shows promise in Phase I Study: TD-1473

    Theravance Biopharma Reports Positive Results From Phase 1 Clinical Trial…

    Read More

  • Admin

    June 2, 2016

    Dementia, yes, but this is not Alzheimer?s

      Looking More Closely at Lewy Body Dementia   University…

    Read More

  • Admin

    June 2, 2016

    Biosimilar nomenclature: Deadline August 2 for comments on FDA’s OMB information request

    Meaningful suffix may be in for U.S. biologics, biosimilars  …

    Read More

  • Companies waste $122 million for every $1B – need greater investment in project management

    Admin

    June 2, 2016

    Companies waste $122 million for every $1B – need greater investment in project management

    http://www.projectmanagement.com/articles/331859/Planning–Assessing–Analyzing-and-Monitoring-Country-and-Political-Risk-During-the-PMI-Risk-Management-Process   High Risk Ahead? Project outcomes are better in…

    Read More

  • Admin

    June 2, 2016

    Genetically modified T-cell therapy granted enhanced EMA regulatory pathway: KTE-C19

    Kite Pharma granted access to PRIME regulatory support for KTE-C19…

    Read More

Previous Page
1 … 7 8 9 10 11 … 13
Next Page

3Sixty Pharma Solutions

Nimble Support With Experienced Helping Hands across the development and commercialization lifecycle.

Quick Links

  • Who We Are
  • How We Partner
  • Solutions
  • Therapeutic Depth
  • News
    • Happy New Year – 2025!
    • Tips to Quell “Firefighting” in Clinical Research
    • Now Playing on ACRPtv!
    • “7 Breakthrough Behaviors” at PMI NJ Meeting
    • Clinical Trial Financial Management – Live Virtual Training
    • Join us for an interactive webinar!
    • Exciting News! 3Sixty Pharma Solutions Partners with Westchester Biotech Project
    • Join me for an interactive webinar!
    • 3Sixty Pharma Solutions’ CEO to Speak at the Functional Services CRO Partnerships Conference
    • Successful Submission of Start-Up Biotech Investigational New Drug Application
    • See You at the Rare Disease Research Symposium 2019
    • Want to apply for NIH funding, but not sure where to start?
    • ‘Thank You’ for Attending ACRP Presentations!
    • Great Conversations at ACRP in Nashville!
  • Contact Us
  • Privacy Policy

Contact Details

Address:

1950 Butler Pike, Ste. 126-175

Phone:

+1 610-941-4750

Email:

contact@3sixtypharma.com

  • LinkedIn

©2025 3Sixty Pharma Solutions. All rights reserved.

Loading Comments...